Approvals/TGA/FLUBLOK trivalent recombinant influenza vaccine, Influenza haemagglutinin recombinant 135 mcg, 0.5 mL solution for injection syringe

Approved

STANDARD

FLUBLOK trivalent recombinant influenza vaccine, Influenza haemagglutinin recombinant 135 mcg, 0.5 mL solution for injection syringe

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: cc9a33e21e5e070d
Product Name: FLUBLOK trivalent recombinant influenza vaccine, Influenza haemagglutinin recombinant 135 mcg, 0.5 mL solution for injection syringe
Artg Id: 446791
Artg Name: FLUBLOK trivalent recombinant influenza vaccine, Influenza haemagglutinin recombinant 135 mcg, 0.5 mL solution for injection syringe
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2025-05-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/40f98ae2be78173d07ad907ae7e94a0a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

cc9a33e21e5e070d

Type

Standard